pH-Activated Targeting Drug Delivery System Based on the Selective Binding of Phenylboronic Acid
Source abstract
Abstract
Phenylboronic acid (PBA) is a tumor-targeting molecule, but its nonspecific interaction with normal cells or other components containing cis-diol residues undoubtedly limits its potential application in tumor-targeting drug delivery. Herein, we developed fructose-coated mixed micelles via PBA-terminated polyethylene glycol monostearate (PBA-PEG-C18) and Pluronic P123 (PEG20-PPG70-PEG20) to solve this problem, as the stability of borate formed by PBA and fructose was dramatically dependent on pH. The fluorescence spectroscopic results indicated that the borate formed by PBA and fructose decomposed at a decreased pH, and better binding between PBA and sialic acid (SA) was observed at a low pH. These results implied that the fructose groups decorated on the surface of the micelles could be out-competed by SA at a low pH. In vitro uptake and cytotoxicity studies demonstrated that the fructose coating on the mixed micelles improved the endocytosis and enhanced the cytotoxicity of drug-loaded mixed micelles in HepG2 cells but reduced the cytotoxicity in normal cells. These results demonstrate that a simple decorating strategy may facilitate PBA-targeted nanoparticles for tumor-specific drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Biomedical Polymers of Ministry of Education and College of Chemistry and Molecular Science, Wuhan University, Wuhan 430072, China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China
References (36)
Show source-provided references
1. 10.1002/anie.20120333910.1002/anie.201203339 ↗
2. 10.1021/bm500300910.1021/bm5003009 ↗
3. 10.1002/smll.20140258110.1002/smll.201402581 ↗
4. 10.1039/c2cc34225a10.1039/c2cc34225a ↗
5. 10.1002/adfm.20130130910.1002/adfm.201301309 ↗
6. 10.1021/bc800006210.1021/bc8000062 ↗
7. 10.1021/nl903411s10.1021/nl903411s ↗
8. 10.1021/nl403733z10.1021/nl403733z ↗
9. 10.1016/j.biomaterials.2008.11.02710.1016/j.biomaterials.2008.11.027 ↗
10. 10.1039/C5PY00013K10.1039/C5PY00013K ↗
11. 10.1002/adhm.20130001310.1002/adhm.201300013 ↗
12. 10.1021/nl047998710.1021/nl0479987 ↗
13. 10.1039/C4CC04056B10.1039/C4CC04056B ↗
14. 10.1002/anie.20090721010.1002/anie.200907210 ↗
15. 10.1021/ja207005z10.1021/ja207005z ↗
16. 10.1021/am507927w10.1021/am507927w ↗
17. 10.1021/acsami.5b0063110.1021/acsami.5b00631 ↗
18. 10.1016/j.colsurfb.2015.06.03810.1016/j.colsurfb.2015.06.038 ↗
19. 10.1016/j.tet.2004.08.05110.1016/j.tet.2004.08.051 ↗
20. 10.1002/smll.20130284110.1002/smll.201302841 ↗
21. 10.1021/acsami.5b0644510.1021/acsami.5b06445 ↗
22. 10.1002/anie.20100122010.1002/anie.201001220 ↗
23. 10.1021/ja401000m10.1021/ja401000m ↗
24. 10.1021/ja501664f10.1021/ja501664f ↗
25. 10.1016/j.biomaterials.2013.09.04210.1016/j.biomaterials.2013.09.042 ↗
26. 10.1039/c0cc00877j10.1039/c0cc00877j ↗
27. 10.1002/mabi.20110052410.1002/mabi.201100524 ↗
28. 10.1021/ja406406h10.1021/ja406406h ↗
29. 10.1021/mz500035w10.1021/mz500035w ↗
30. 10.1039/C4CC10413G10.1039/C4CC10413G ↗
31. 10.1016/j.biomaterials.2010.12.03910.1016/j.biomaterials.2010.12.039 ↗
32. 10.1016/j.jconrel.2011.10.00510.1016/j.jconrel.2011.10.005 ↗
33. 10.1021/bm401087n10.1021/bm401087n ↗
34. 10.1002/chem.20040133510.1002/chem.200401335 ↗
35. 10.1038/pj.2014.4210.1038/pj.2014.42 ↗
36. 10.1039/C4CC06651K10.1039/C4CC06651K ↗